BIOSCIENCE
REVIEW
PAGE 1
PAGE 2
 
         
   
William Emhiser President, Life Sciences Division
  Susan L. N. Vogt President, BioPharmaceutical Division    

“Our new products for genomics, proteomics and drug development build on our strengths and meet the emerging needs of the fastest moving area in research. ”

“We are very good at purifying proteins with our range of technology and our application expertise. The expanding number of biotech drugs in development and in clinical trials is a predictor of our future potential in biotech manufacturing.”
 
 
 

Revenue Growth 1999 - 2000
(in percent)
*local currency


next page